PATENT CLAIM ANALYSIS

Application Number: 15939837
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "294000"]

Abstract:
This invention relates to the use of combinations of stereoisomers of dihydrotetrabenazine for the treatment of movement disorders, such as Tourette's syndrome.

Claim (Index 12):
A method of treating a hyperkinetic movement disorder (such as Huntington's disease, hemiballismus, senile chorea, tic disorders, tardive dyskinesia, dystonia and Tourette's syndrome) in a subject in need thereof (e.g. a mammalian subject such as a human), which method comprises administering to the subject a therapeutically effective amount of a pharmaceutical combination comprising\n (a) (+)-\u03b2-dihydrotetrabenazine, or a pharmaceutically acceptable salt thereof; and one or both of: (b) (\u2212)-\u03b1-dihydrotetrabenazine, or a pharmaceutically acceptable salt thereof; and (c) (+)-\u03b1-dihydrotetrabenazine, or a pharmaceutically acceptable salt thereof; or a pharmaceutical unit dosage form comprising said pharmaceutical combination and a pharmaceutically acceptable excipient.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 90.0
- Lexical Diversity: 1.19048
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15939826', '12555695', '15044655', '15071797', '14030322']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7344058321159518
- 35 USC 102 Novelty (BERT): 0.6094108955625867
- Combined Prediction Score: 0.7219063384606152
- Mean Citation Score: 358.154622
- Max Citation Score: 664.932
- Similarity Product: 438.0627541565895

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test